OMNI Successfully Completes CMMI Level 3 Benchmark Appraisal Across Six Critical Domains
This distinction eliminates common program execution risks and ensures process integrity, consistency, and accountability from proposal through delivery.
The CMMI appraisal validates that OMNI's processes are embedded, repeatable, and enforced enterprise-wide. These certified practices govern how OMNI designs and delivers secure software, manages suppliers, supports personnel, and operates in virtual and distributed environments, providing federal customers with measurable assurance of quality, security and performance.
"This benchmark appraisal confirms what our customers experience every day. OMNI operates with discipline, transparency and rigor at scale," said
This milestone reflects OMNI's ongoing commitment to reducing delivery risk, accelerating outcomes, and safeguarding government investments through proven, certified operational excellence.
About OMNI
OMNI is a trusted provider of Digital Transformation Solutions focused on end-user empowerment, tackling complex mission challenges and disrupting the status quo by driving successful outcomes at the speed of mission. OMNI harnesses the power of User Centered Design, DevSecOps, Rapid Software Development, Enterprise Cloud and Platform Solutions, Offensive and Defensive Cyber Solutions and couples these capabilities with data solutions, artificial intelligence (AI) and automation. OMNI integrates a commercial mindset and innovation with keen focus on unique DoD, IC and Federal requirements of each mission. For more information, visit omnifederal.com.
Media Contact:
410-216-9447
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/omni-successfully-completes-cmmi-level-3-benchmark-appraisal-across-six-critical-domains-302681995.html
SOURCE Omni Federal
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Thryv and Wix announce SMB-focused strategic partnership
- iBio names endocrinologist Molly Carr as chief medical officer
- Nurix earns $10M milestone as Sanofi starts STAT6 degrader trial
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share